Literature DB >> 22692724

Changes on brief cognitive instruments over time in Parkinson's disease.

Stephanie Lessig1, Dong Nie, Ronghui Xu, Jody Corey-Bloom.   

Abstract

Two hundred and twenty-one subjects with Parkinson's disease (PD) were examined using the Mini-Mental Status Examination (MMSE) and Montreal Cognitive Assessment (MoCA), with a subset of these (n = 98) examined on repeat testing up to 3 years. The MoCA was more sensitive in identifying cognitive deficit, specifically in the domains of visuospatial abilities, language, and memory. In longitudinal study, the MMSE changed significantly over time, particularly in patients with disease duration of >10 years. The MoCA, however, did not change significantly, even when subjects were stratified by age, MMSE score, and disease duration. This suggests that the MoCA may be more sensitive for detecting early cognitive change in PD, but that the MMSE, and not the MoCA, may be better for tracking cognitive decline.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22692724     DOI: 10.1002/mds.25070

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  30 in total

1.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek; Kyoung-Min Lee; Ji-Young Kim; Jee-Young Lee; Hee Jin Kim; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Gwanhee Ehm
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease.

Authors:  Marta Kaminska; Victoria P Mery; Anne-Louise Lafontaine; Ann Robinson; Andrea Benedetti; Priti Gros; R John Kimoff
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

3.  Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.

Authors:  A Markser; Franziska Maier; C J Lewis; T A Dembek; D Pedrosa; C Eggers; L Timmermann; E Kalbe; G R Fink; Lothar Burghaus
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

4.  Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.

Authors:  Daniel S Brown; Ira H Bernstein; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Mustafa Husain; Laura H Lacritz
Journal:  Int J Geriatr Psychiatry       Date:  2015-07-14       Impact factor: 3.485

5.  Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?

Authors:  Jane E Alty; Jeremy Cosgrove; Stuart Jamieson; Stephen L Smith; Katherine L Possin
Journal:  Clin Neurol Neurosurg       Date:  2015-10-17       Impact factor: 1.876

6.  Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP.

Authors:  Chang-He Shi; Jonathan C Schisler; Carrie E Rubel; Song Tan; Bo Song; Holly McDonough; Lei Xu; Andrea L Portbury; Cheng-Yuan Mao; Cadence True; Rui-Hao Wang; Qing-Zhi Wang; Shi-Lei Sun; Stephanie B Seminara; Cam Patterson; Yu-Ming Xu
Journal:  Hum Mol Genet       Date:  2013-10-09       Impact factor: 6.150

7.  Effects of Normative Adjustments to the Montreal Cognitive Assessment.

Authors:  Erika A Pugh; Emily C Kemp; Christopher H van Dyck; Adam P Mecca; Emily S Sharp
Journal:  Am J Geriatr Psychiatry       Date:  2018-09-21       Impact factor: 4.105

8.  MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.

Authors:  Roberta Biundo; L Weis; S Bostantjopoulou; E Stefanova; C Falup-Pecurariu; M G Kramberger; G J Geurtsen; A Antonini; D Weintraub; D Aarsland
Journal:  J Neural Transm (Vienna)       Date:  2016-02-06       Impact factor: 3.575

9.  Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.

Authors:  Kelvin L Chou; Adrienne Lenhart; Robert A Koeppe; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2014-07-19       Impact factor: 4.891

10.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.